Dysfunctional uterine bleeding.

In: Canadian journal of surgery. Journal canadien de chirurgie · 1986 · vol. 29(5) , pp. 305–7 · PMID:3019496 · W2466981966
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-17 ⓘ

This paper defines dysfunctional uterine bleeding as abnormal bleeding without organic disease, outlining diagnostic strategies and medical treatments aimed at modifying endometrial hormone production or prostaglandin synthesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Dysfunctional uterine bleeding is defined as abnormal uterine bleeding in the absence of organic disease. It is the result of anovulation or the abnormal local production of prostaglandins, and in each case the primary fault is inappropriate hormone formation. There are two approaches to diagnosis. The traditional one is primarily concerned with the exclusion of cancer of the endometrium; this concern results in the frequent resort to uterine curettage. The second approach is to limit curettage to patients whose symptoms are not ameliorated by medical therapy. The aim of medical treatment is either to produce secretory change in the endometrium or to decrease the formation of uterine prostaglandins. Intermittent progesterone treatment is used to cause secretory changes in the endometrium. Decreased production of the prostaglandins is achieved indirectly by causing atrophy of the endometrium or directly through the use of prostaglandin synthetase inhibitors. Surgery in the form of dilatation and curettage has no long-term therapeutic effect; hysterectomy is definitive therapy.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK